This inventor holds 11 USPTO granted patents. Top assignees: National Research Development Corporation, British Technology Group Limited, Warner-Lambert Company. Active years: 1986-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxted, GB (1986 - 1988)
- Farringdon, GB (1992 - 1996)
- Faringdon, GB (1994 - 1996)
- Woolstone, GB (1997)
- Didcot, GB (1997)
Company Filing History:
5 out of 1,200 
4 out of 328 
4 out of 2,538 Years Active: 1986-1997
Title: The Innovative Journey of Ian J Stratford
Introduction: Ian J Stratford, renowned inventor based in Faringdon, GB, has made significant contributions to the field of chemical compounds with a notable portfolio of 11 patents. His innovative work focuses on developing chiral compounds that serve as radiosensitizers and chemosensitizers, enhancing therapeutic strategies for treating solid tumors.
Latest Patents: Among Ian's latest patents include the compound "Chiral [(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol." This innovative formula represents a crucial advancement in medicinal chemistry. Another significant patent involves chiral compounds utilized as radiosensitizers or chemosensitizers, described with an intricate formula where X denotes a halogen or specific intermediates crucial for preparation. Furthermore, he has detailed a novel process for producing these compounds, showcasing a sophisticated approach in potentiating bioreductive agents. This process touches on the treatment of human or animal subjects with solid tumors by administrating effective amounts of a nitric oxide synthase inhibitor alongside an imidazole or 1,2,4-triazole derivative.
Career Highlights: Ian's professional journey takes him through esteemed organizations such as the National Research Development Corporation and British Technology Group Limited. His experiences in these institutions have greatly contributed to his development as a pivotal figure in the realm of chemical innovations.
Collaborations: Throughout his career, Ian has collaborated with notable individuals such as Gerald E Adams and Edward M Fielden, enhancing the scope and impact of his research efforts. These partnerships underscore the collaborative spirit vital for innovation in complex scientific fields.
Conclusion: Ian J Stratford exemplifies the essence of innovation with his groundbreaking work in the development of chiral compounds and their applications in medical treatments. His extensive patent portfolio and collaborative efforts highlight his commitment to advancing science, ultimately benefiting therapeutic practices for solid tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile